The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node

被引:16
作者
Argon, Aziz Murat [1 ]
Duygun, Ulkem
Acar, Ebru
Daglioz, Gozde
Yenjay, Levent
Zekioglu, Ozman
Kapkac, Murat
机构
[1] Ege Univ, Fac Med, Dept Nucl Med, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Gen Surg, Izmir, Turkey
[3] Ege Univ, Fac Med, Dept Pathol, Izmir, Turkey
关键词
gamma probe detection; sentinel lymph node biopsy; breast cancer; periareolar injection; intradermal injection;
D O I
10.1097/01.rlu.0000246855.80027.b7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Purpose: The purpose of the present study was to evaluate the use of lymphoscintigraphy, blue dye, and gamma probe detection methods for determination of the sentinel lymph node (SLN) using both periareolar intradermal injection of Tc-99m tin colloid and peritumoral intraparenchymal injection of isosulfan blue dye. Methods: One hundred patients with T1-2 breast cancer and clinically negative nodes were enrolled in the present study. The study was composed of 2 groups. Backup axillary lymph node dissection (ALND) was mandatory in group 1 (20 patients) regardless of their lymph node status. In group 2 (80 patients), complete ALND was performed when intraoperative frozen section analysis of SLN revealed metastases. Otherwise, only SLN biopsy was performed without ALND. One day before surgery, Tc-99m tin colloid was injected at 4 periareolar sites intradermally. Lymphoscintigraphy was performed 1 to 2 hours after injection of the radiocolloid. Twenty minutes before surgery, isosulfan blue dye was injected into parenchyma surrounding the tumor or the biopsy cavity. Results: The detection rates of SLN and false-negative rate of lymphoscintigraphy, blue dye, and gamma probe detection were 85%, 95% 100%, and 0% in group 1, 91%, 87%, and 95% in group 2, respectively. Detection rate by the combination of blue dye and radio tracer was 98%. Conclusions: According to the results of our study, we conclude that perioareolar intradermal injection of Tc-99m tin colloid combined with peritumoral intraparenchymal injection of blue dye is an accurate and easy method of locating the sentinel node with very high detection rates. It is recommended that the combination of all methods such as lymphoscintigraphy, blue dye, and gamma probe application will increase the success rate of SLN detection in patients with breast cancer.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 33 条
[1]
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]
*AM INT, 1984, AM HEP 2 PROD INF
[3]
Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy [J].
Babiera, GV ;
Delpassand, ES ;
Breslin, TM ;
Ross, MI ;
Ames, FC ;
Singletary, SE ;
Kuerer, HM ;
Feig, BW ;
Meric-Bernstam, F ;
Hunt, KK .
CLINICAL NUCLEAR MEDICINE, 2005, 30 (01) :11-15
[4]
Sentinel node detection and definition may depend on the imaging agent and timing [J].
Boxen, I ;
McCready, D ;
Ballinger, JR .
CLINICAL NUCLEAR MEDICINE, 1999, 24 (06) :390-394
[5]
VALUE OF AXILLARY DISSECTION IN ADDITION TO LUMPECTOMY AND RADIOTHERAPY IN EARLY BREAST-CANCER [J].
CABANES, PA ;
SALMON, RJ ;
VILCOQ, JR ;
DURAND, JC ;
FOURQUET, A ;
GAUTIER, C ;
ASSELAIN, B .
LANCET, 1992, 339 (8804) :1245-1248
[6]
Evaluation of sentinel lymph nodes in breast cancer [J].
Cserni, G ;
Weaver, DL .
HISTOPATHOLOGY, 2005, 46 (06) :697-706
[7]
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines [J].
Cserni, G ;
Amendoeira, I ;
Apostolikas, N ;
Bellocq, JP ;
Bianchi, S ;
Bussolati, G ;
Boecker, W ;
Borisch, B ;
Connolly, CE ;
Decker, T ;
Dervan, P ;
Drijkoningen, M ;
Ellis, IO ;
Elston, CW ;
Eusebi, V ;
Faverly, D ;
Heikkila, P ;
Holland, R ;
Kerner, H ;
Kulka, J ;
Jacquemier, J ;
Lacerda, M ;
Martinez-Penuela, J ;
De Miguel, C ;
Peterse, JL ;
Rank, F ;
Regitnig, P ;
Reiner, A ;
Sapino, A ;
Sigal-Zafrani, B ;
Tanous, AM ;
Thorstenson, S ;
Zozaya, E ;
Wells, CA .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) :1654-1667
[8]
Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO
[9]
2-H
[10]
Mapping a pathway for axillary staging - A personal perspective on the current status of sentinel lymph node dissection for breast cancer [J].
Giuliano, AE .
ARCHIVES OF SURGERY, 1999, 134 (02) :195-199